A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment

Hepatology International

from Gastroenterology via xlomafota13 on Inoreader http://ift.tt/1LtatJT
via IFTTT